VAXCYTE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.19 USD | -0.58% |
|
-1.17% | +3.81% |
| May. 08 | Vaxcyte, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 25 | Vaxcyte Insider Sold Shares Worth $928,845, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VAXCYTE, INC. | Bio Therapeutic Drugs | -0.58% | -1.17% | +3.81% | +30.25% | - | 7.09B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- PCVX Stock
- Charts Vaxcyte, Inc.
- Comparison Chart